ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Silicon Labs

Silicon Labs (SLAB)

218,42
0,47
(0,22%)
Fermé 28 Juin 10:00PM
218,42
0,14
(0,06%)
Après les heures de négociation: 12:55AM

Silicon Labs ([symbol]) Options

Achats

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
160,0057,2060,7056,0058,950,000,00 %025-
165,0052,3055,7048,3054,000,000,00 %01-
170,0047,3050,700,0049,000,000,00 %00-
175,0042,4045,8044,1044,1034,60364,21 %1226/6/2026
180,0037,2040,808,8039,000,000,00 %01-
185,0032,4035,8022,0034,100,000,00 %01-
190,0027,6030,9021,6029,250,000,00 %02-
195,0022,6026,0024,3024,307,2042,11 %1126/6/2026
200,0017,7021,0011,1619,350,000,00 %08-
210,007,3011,209,859,250,000,00 %041-
220,000,053,001,001,5250,000,00 %0989-
230,000,050,100,050,0750,000,00 %252 88326/6/2026
240,000,000,050,050,050,000,00 %0237-
250,000,000,700,700,700,000,00 %0102-
260,000,002,150,630,630,000,00 %039-
270,000,000,750,050,050,000,00 %0149-

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Ventes

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
160,000,002,150,600,600,000,00 %01-
165,000,002,150,000,000,000,00 %00-
170,000,002,150,800,800,000,00 %01-
175,000,002,150,650,650,000,00 %020-
180,000,002,200,650,650,000,00 %059-
185,000,052,250,251,150,000,00 %0193-
190,000,000,500,400,400,000,00 %0296-
195,000,000,700,400,400,000,00 %0489-
200,000,050,500,500,2750,000,00 %0422-
210,000,052,101,001,0750,000,00 %039-
220,000,504,703,602,600,000,00 %01-
230,009,6013,4012,3911,500,000,00 %01-
240,0019,6023,4020,8221,500,000,00 %00-
250,0029,6033,500,0031,550,000,00 %00-
260,0039,6043,500,0041,550,000,00 %00-
270,0049,6053,500,0051,550,000,00 %00-

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SDOTSadot Group Inc
US$ 20,93
(238,67%)
45,35M
PCLAPicoCELA Inc
US$ 6,591
(114,69%)
7,43M
IVFINVO Fertility Inc
US$ 2,44
(96,77%)
115,64M
WSHPWeShop Holdings Ltd
US$ 7,85
(66,67%)
8,28M
INLFINLIF Limited
US$ 0,0462
(54,00%)
2,27B
PSIGPS International Group Ltd
US$ 1,52
(-87,12%)
19,32M
CELZCreative Medical Technology Holdings Inc
US$ 1,184
(-41,67%)
552,45k
LICNLichen International Ltd
US$ 1,02
(-38,92%)
15,6M
BTCTBTC Digital Ltd
US$ 0,7212
(-36,74%)
1,46M
BEGLeverage Shares 2X Long BE Daily ETF
US$ 59,86
(-36,06%)
274,83k
INLFINLIF Limited
US$ 0,0462
(54,00%)
2,27B
GDCGD Culture Group Ltd
US$ 0,01085
(-20,80%)
520,95M
RCTRedCloud Holdings PLC
US$ 0,344
(21,60%)
267,55M
AAPLApple Inc
US$ 283,78
(3,14%)
261,95M
AMZNAmazon.com Inc
US$ 232,69
(2,50%)
248,53M
Eli's Gone Eli's Gone il y a 3 minutes
GL...
halldorson halldorson il y a 4 minutes
Interesting read -
Wall Street Peer ComparisonsTo gauge where a successful medical device company in this niche can trade, retail investors often look at peer companies targeting localized cancer therapies:Company / Asset ClassClinical StageTypical

Market Cap Visualized Equiv
RDGL
CatfishHunter CatfishHunter il y a 4 minutes
Thanks for sharing the details on the Duke/Schaal ELP + I-131 work.

The 2022 Nature Biomedical Engineering paper showed impressive preclinical results in mouse pancreatic cancer models (strong tumor regression, especially combined with nanoparticle paclitaxel). That’s meaningful data
RDGL
Seminole Red Seminole Red il y a 7 minutes
97,11,5,71
PEACHMAN PEACHMAN il y a 8 minutes
I suggest people read your informative IFUS post again so that it makes sense with my comments

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177740678

YOU stated

If I were the interim CEO of IFUS right now, what would I do? Let's just set
IFUS
Whalatane Whalatane il y a 9 minutes
UNCY's UniSource hub .
I suggest you all read up on this B2B plan UNCY is starting to make it really easy for dialysis centers to prescribe , store and bill for OLC .
Its designed to over come a lot of the hurdles , drug co's face launching new drugs into a field dominated by Freseniu
UNCY
Zadie420 Zadie420 il y a 10 minutes
Exactly eagle8.
I think once we use DCVax-L plus Poly-ICLC, DCVax-D+ and aDC1 treatments in other cancer types we will see tremendous price movement.
NWBO
porty porty il y a 13 minutes
Well, I don’t have my shares yet so they are worth nothing. More optimistic now that I might actually get them. 
GTVH
gorbec1 gorbec1 il y a 14 minutes
Let the piggy bank eat .


The excitement builds
MCIC
OracleWitch66 OracleWitch66 il y a 14 minutes
You  as well aqua
FITY
OracleWitch66 OracleWitch66 il y a 15 minutes
Hell yeah kj thanks for all your DD much appreciated let's go FITY
FITY
Musical Shares Musical Shares il y a 16 minutes
In over 25 years

It's quite a feature, isn't it?

What seems to always be missing here is that RadioGel was NOT the first thermogel with a radionuclide. It's even in their "prior art" section on their original patent from 1998!

And there have been many oth
RDGL
eagle8 eagle8 il y a 16 minutes
starric, as usual, thanks for your posts.

The ultimate goal for NWBO is, of course, DCvax-Direct.
With the Kalinski method, aDCs, we won't need many adjuvants anymore.
Then only the companies with the most necessary adjuvants will benefit.
And there aren't that ma
NWBO
barnstormer barnstormer il y a 16 minutes
Brazen. Boilerplate noise no, but boilerplate regardless. It's regulatory language the company has to keep repeating until the regulator approves the product. When I noted the language was also written to protect the company from litigation, I was referring to the whole regulatory document. Its car
NWBO
3331 3331 il y a 18 minutes
$250K IS THE MAGIC NUMBER!  
$250,000 profit will get the PPS to COPPER @ P/E = 1,000 (not unusual for stocks turning profitable for the first time and with increasing future growth/revenue/profit projections).  This will happen when investors are confident the profit will be achieved, likely
BIEL
jimr1717 jimr1717 il y a 19 minutes
16 years of the same Ruse. No one is Fooled
IFUS
Investor2014 Investor2014 il y a 20 minutes
Also carefully read section 2.6.9. Discussion on clinical safety.

That safety discussion is not comparable to a normal approved-drug safety review where risks are identified, quantified, labelled and managed. CHMP found that blarcamesine’s safety package was too small for a large chr
AVXL
CanadianInvestor1 CanadianInvestor1 il y a 22 minutes
Check video out at 3:55 and 5:11.
KNBIF
CanadianInvestor1 CanadianInvestor1 il y a 23 minutes
New CEO took over 1.5 years ago. Lots of trial data in the last year shows the efficacy of Revyve. Recent video says this is a good time for entry to the US market, due to changes in Medicare rules last year pushing skin subs (competitors to KNBIF) out of business. https://wallstreetanalyzer.com/202
KNBIF
William777 William777 il y a 24 minutes
Drilling down on JB statement, "NutraNomics looks forward to further collaboration announcements with RE Strategies in the near future."
What strategies are coming our way?
NNRX
SSKILLZ1 SSKILLZ1 il y a 24 minutes
They win a game so the response is to rest lindor, sit aj ewing, and start mark vientos because he is so good defensively at 1b, at 3b he should even be better at this point, wagaman at 1b, baty at 2b, they could get the same result by simply forfeiting the game. And Kodai Senga who should have been
MONTI KING MONTI KING il y a 25 minutes
I think it’s important to keep in mind that givebux valued VitOrgan/ shop at 39 million almost two years ago.. that was for just 1 piece. VitOrgan decided not to complete the LOI.. and here we are!

The $39 million figure came directly from GivBux’s February 3, 2025, press release an
VGLS
pos_stock_hoarder pos_stock_hoarder il y a 27 minutes
Gene Chandler - The Duke of Earl
https://youtu.be/Qa88gqvXJMc
cashclan cashclan il y a 27 minutes
Probably has nothing


To do with the bullet points.

Liquidity is drying up. No, Liquidity you get a crash. Happened in 1929.

July 4th Independency Day. Without Liquidity the old system has 3 days to critical mass of no return. Then 10 days of f
SPCX

Dernières Valeurs Consultées

Delayed Upgrade Clock